These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 19423296

  • 1. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C, Rubio G.
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [Abstract] [Full Text] [Related]

  • 2. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA, Edelbroek PM, Gorter JA.
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [Abstract] [Full Text] [Related]

  • 3. Levetiracetam as add-on therapy in different subgroups of "benign" idiopathic focal epilepsies in childhood.
    von Stülpnagel C, Kluger G, Leiz S, Holthausen H.
    Epilepsy Behav; 2010 Feb; 17(2):193-8. PubMed ID: 20045383
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS, Benatar M.
    Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
    [Abstract] [Full Text] [Related]

  • 5. Use of levetiracetam in hospitalized patients.
    Falip M, Carreño M, Amaro S, Donaire A, Delgado R, Toledo M, Maestro I.
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute psychosis associated with levetiracetam.
    Youroukos S, Lazopoulou D, Michelakou D, Karagianni J.
    Epileptic Disord; 2003 Jun; 5(2):117-9. PubMed ID: 12875956
    [Abstract] [Full Text] [Related]

  • 10. Levetiracetam as a treatment option in non-convulsive status epilepticus.
    Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G.
    Epilepsy Res; 2007 Mar; 73(3):238-44. PubMed ID: 17161587
    [Abstract] [Full Text] [Related]

  • 11. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB, Conry JA, Rodríguez-Leyva I, Gutierrez-Moctezuma J, Salas E, Coupez R, Stockis A, Lu ZS.
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [Abstract] [Full Text] [Related]

  • 12. Nonconvulsive status epilepticus on treatment with levetiracetam.
    Atefy R, Tettenborn B.
    Epilepsy Behav; 2005 Jun; 6(4):613-6. PubMed ID: 15876554
    [Abstract] [Full Text] [Related]

  • 13. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 14. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A.
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [Abstract] [Full Text] [Related]

  • 15. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S, Muroi C, Seule M, Bjeljac M, Keller E.
    Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
    [Abstract] [Full Text] [Related]

  • 16. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E, Marson AG, Van Paesschen W, Kälviäinen R, Marovac J, Duncan B, Buyle S, Hallström Y, Hon P, Muscas GC, Newton M, Meencke HJ, Smith PE, Pohlmann-Eden B, KOMET Study Group.
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [Abstract] [Full Text] [Related]

  • 17. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
    Tanaka S, Tanaka T.
    Epileptic Disord; 2013 Jun; 15(2):132-41. PubMed ID: 23774199
    [Abstract] [Full Text] [Related]

  • 18. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group.
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [Abstract] [Full Text] [Related]

  • 19. Levetiracetam in children with refractory status epilepticus.
    Gallentine WB, Hunnicutt AS, Husain AM.
    Epilepsy Behav; 2009 Jan; 14(1):215-8. PubMed ID: 18926926
    [Abstract] [Full Text] [Related]

  • 20. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z, N159 Study Group.
    Neurology; 2006 Jun 13; 66(11):1654-60. PubMed ID: 16641323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.